» Articles » PMID: 37568761

Patients' Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways

Abstract

Aims: To describe patients' experiences of pre-diagnostic signs/symptoms and pathways to diagnosis, including where help was sought, and the processes involved.

Methods: Mixed methods involving quantitative, qualitative and inductive thematic analyses using novel process mapping of patient journey data, as reported by the patients. We examined the time from symptom onset to first professional presentation (patient interval, PI), first consultation to diagnostic biopsy, first consultation to diagnosis (diagnostic interval) and first presentation to diagnosis (total interval).

Results: A total of 87 interviews were conducted over 5 months in 2017. Of these, 78 (40 males/38 females) were included. The sarcoma subtypes were bone (n = 21), soft tissue (n = 41), head and neck (n = 9) and gastro-intestinal (GIST; n = 7). Age at diagnosis was 13-24 (n = 7), 25-39 (n = 23), 40-64 (n = 34) and 65+ (n = 14) years. The median PI was 13 days (1-4971) and similar between sarcoma subtypes, with the exception of GIST (mPI = 2 days, (1-60). The longest mPI (31 days, range 4-762) was for those aged 13-24 years. The median diagnostic interval was 87.5 (range 0-5474 days). A total of 21 patients were misdiagnosed prior to diagnosis and symptoms were commonly attributed to lifestyle factors.

Conclusions: Prolonged times to diagnosis were experienced by the majority of patients in our sample. Further research into the evolution of pre-diagnostic sarcoma symptoms is required to inform awareness interventions.

Citing Articles

Nomenclature of the symptoms of head and neck cancer: a systematic scoping review.

Bradley P, Lee Y, Albutt A, Hardman J, Kellar I, Odo C Front Oncol. 2024; 14:1404860.

PMID: 38952557 PMC: 11216301. DOI: 10.3389/fonc.2024.1404860.


Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors.

de Alava E Virchows Arch. 2024; 484(2):353-367.

PMID: 38228904 PMC: 10948576. DOI: 10.1007/s00428-024-03736-5.

References
1.
Smolle M, Andreou D, Tunn P, Szkandera J, Liegl-Atzwanger B, Leithner A . Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk. EFORT Open Rev. 2017; 2(10):421-431. PMC: 5702952. DOI: 10.1302/2058-5241.2.170005. View

2.
Muscolo D, Ayerza M, Makino A, Costa-Paz M, Aponte-Tinao L . Tumors about the knee misdiagnosed as athletic injuries. J Bone Joint Surg Am. 2003; 85(7):1209-14. DOI: 10.2106/00004623-200307000-00005. View

3.
Mendonca S, Abel G, Saunders C, Wardle J, Lyratzopoulos G . Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English Cancer Patient Experience Survey. Eur J Cancer Care (Engl). 2015; 25(3):478-90. PMC: 4855626. DOI: 10.1111/ecc.12353. View

4.
Grunewald T, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F . Sarcoma treatment in the era of molecular medicine. EMBO Mol Med. 2020; 12(11):e11131. PMC: 7645378. DOI: 10.15252/emmm.201911131. View

5.
Soomers V, Husson O, Young R, Desar I, van der Graaf W . The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes. ESMO Open. 2020; 5(1). PMC: 7046415. DOI: 10.1136/esmoopen-2019-000592. View